Abstract
Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases.
John Darmawan, A Remy Nasution, Shun-Le Chen, Syed Atiqul Haq, Dongbao Zhao, Qingyu Zeng and Fereydoun Davatchi
The Journal of Rheumatology December 2006, 33 (12) 2484-2492;
John Darmawan
A Remy Nasution
Shun-Le Chen
Syed Atiqul Haq
Dongbao Zhao
Qingyu Zeng
In this issue
The Journal of Rheumatology
Vol. 33, Issue 12
1 Dec 2006
Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases.
John Darmawan, A Remy Nasution, Shun-Le Chen, Syed Atiqul Haq, Dongbao Zhao, Qingyu Zeng, Fereydoun Davatchi
The Journal of Rheumatology Dec 2006, 33 (12) 2484-2492;
Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases.
John Darmawan, A Remy Nasution, Shun-Le Chen, Syed Atiqul Haq, Dongbao Zhao, Qingyu Zeng, Fereydoun Davatchi
The Journal of Rheumatology Dec 2006, 33 (12) 2484-2492;